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305 Anxiety and depression: important factors in our understanding
of quality of life
T. Havermans, K. Colpaert, L. Dupont. CF Centre, University Hospital Leuven,
Leuven, Belgium
Aim: To screen for anxiety and depression in adult CF patients and investigate the
relationship between anxiety and depression and domains of quality of life.
Method: The Hospital Anxiety and Depression scale (HADS) and the Cystic Fibro-
sis Questionnaire (CFQ-R) were completed by 47 patients. Demographic variables
included age, gender, partner status and work/school status. Illness parameters were
lung function, BMI and presence an indwelling catheter (PAC). Multiple regression
using forward selection was used to construct models relating these variables to
CFQ-R domains.
Results: Scores on the HADS were low and not different from normative scores.
No differences in HADS scores were found in relation to demographic or illness
parameters. Depression contributed to models explaining variance in the domains
physical (with gender and work, R2 = 0.55, p< 0.001) and body image (with BMI,
R2 = 0.43, p< 0.001). Anxiety contributed to models in the domains vitality (with
gender, R2 = 0.45, p< 0.001); eating problems (with BMI, R2 = 0.29, p< 0.001);
treatment problems (with age and PAC, R2 = 0.40, p< 0.001); role (with work status,
R2 = 0.48, p< 0.001); respiratory problems (with gender, R2 = 0.55, p< 0.001)
and digestive problems (with age, R2 = 0.19, p< 0.05). Anxiety and depression
contributed to models in the domains emotional problems (with BMI, R2 = 0.68,
p< 0.001); health (with FEV1 and gender, R
2 = 0.66, p< 0.001) and social problems
(with gender, R2 = 0.50, p< 0.001).
Conclusions: The screening results show that the patients in our clinic do not report
higher on anxiety or depression than expected. Anxiety and depression were found
to signiﬁcantly contribute to models explaining variance in quality of life. Screening
for anxiety and depression may add to our understanding of the perception of QoL
and provide directions for interventions.
306 Improving the quality of life for CF patients by facilitating their
creativity
H. Chladova, P. Hodkova, T. Tesarova. Czech CF Association, Prague 5, Czech
Republic
The aim of high-quality psycho-social care for people suffering from CF is to offer
the activities for patients of all ages either during the home care or in the hospital.
During routine care, necessary care methods and procedures can lead to the feeling
of life-scheming. At the same time the emotional balance and the way the patient
himself treats it, is a very important thing of attitude toward himself – and in this
case to his illness itself.
Discovering new sources of own creativity and their stimulation are the most natural
ways to recover the new emotional balance.
Our poster shows suggestions of different activities for applying and using in the
conditions of our Prague CF centre.
Supported by: CF centre Prague.
307 Effects of a clinic-based intervention on caregiving stress for
parents of children with CF
L. McDonald, A.L. Quittner, M.E. Grimley, M. Botteri, D.H. Barker. University
of Miami, Coral Gables, FL, USA
Objectives: Prior research indicates that mothers caring for a child with CF report
higher levels of stress than parents of children without CF (Quittner et al., 1998).
Furthermore, parents rated illness-speciﬁc tasks (e.g., doing treatments) as more
stressful than typical parenting tasks (e.g., discipline). The purpose of the current
study was to evaluate how an intervention that targeted adherence to medical
regimens in young children with CF impacted caregiver stress. It was hypothesized
that participation in this intervention would decrease parenting stress, particularly
in CF-speciﬁc stressors.
Methods: As part of a larger intervention study at 3 CF Centers, 88 children with
CF ages 1 to 11 and their parents were randomly assigned to either an Immediate
Treatment (I) or Wait-list Control (WL) group. All parents completed both the
Family Stress Scale (FSS) and the Parenting Stress Index (PSI) at Baseline and
Post-Intervention.
Results: At Baseline, the average level of stress as measured by the FSS was similar
in both groups (I = 2.20, WL= 2.12). After controlling for maternal education and
income, no change was found in the mean level of stress from Baseline to Post-
Intervention. Top-ranked CF stressors at both time points were: eating more calories,
explaining CF to child, and doing treatments. At Post-Intervention, higher levels of
stress were associated with more symptoms of depression (r = 0.58, p< 0.05).
Conclusions: Overall, parents reported higher stress for CF than non-CF speciﬁc
tasks. Higher levels of stress were also associated with more depressive symptoms.
Further analyses will be conducted to identify possible patterns of change in stress
levels among these families.
Funding was provided by NIH grant #69736.
308 Comparison of sleep quality, anxiety and depression between
mothers of children with cystic ﬁbrosis and with asthma
O. Yilmaz1, S. Gulle2, A. Sogut1, D. Can2, H. Yuksel1. 1Celal Bayar University,
Pediatric Allergy and Pulmonology, Manisa, Turkey; 2Behcet Uz Children’s
Hospital, Pediatric Allergy and Pulmonology, Izmir, Turkey
Chronic diseases in children may impair sleep quality of mothers and may be risk
for depression and anxiety. Aim of this study was to compare sleep quality, anxiety
and depression in mothers of children with cystic ﬁbrosis (CF) and asthma as two
chronic respiratory diseases.
Mothers of 12 children with CF, 75 with asthma and 45 healthy children were
included. Pittsburgh sleep quality and hospital anxiety-depression questionnaires
were given to mothers. Higher scores indicate worse outcome in scales.
Subjective sleep quality, sleep efﬁciency and total Pittsburgh scores were not differ-
ent between mothers of children CF and asthma (p = 0.15, 0.47, 0.35 respectively).
Frequency of healthy sleep was not different between CF and asthma groups (44.4%
vs 63.3%, p = 0.38). Mean anxiety and depression scores were not signiﬁcantly
different between the two groups(p = 0.57 and 0.73 respectively). When mothers
of children with CF were compared with those of healthy controls, there was a
signiﬁcant difference between subjective sleep quality and total Pittsburgh scores
(1.5±0.9 and 5.8±2.2 in CF vs 0.7±0.8 and 3.9±2.8 in control, p = 0.016 and
0.041 respectively). Frequency of healthy sleep in the control group (86.7%) was
signiﬁcantly higher than the CF group (p = 0.03). Anxiety and depression scores
were insigniﬁcantly higher in mothers in CF group than controls(p = 0.42 and 0.19
respectively).
In conclusion, CF in children may impair sleep quality and may pose a risk for
anxiety and depression in mothers when compared to mothers of healthy children.
However when two chronic respiratory diseases are compared, the nature of disease
does not seem to make a signiﬁcant difference.
